Your browser doesn't support javascript.
loading
Optimisation of a pyrazole series of progesterone antagonists; Part 1.
Dack, Kevin N; Skerratt, Sarah; Johnson, Patrick S; Bradley, Paul A; Marsh, Ian R.
Affiliation
  • Dack KN; Department of World-Wide Medicinal Chemistry, Pfizer PharmaTherapeutics Division, Sandwich CT 13 9NJ, UK. kevin.dack@pfizer.com
Bioorg Med Chem Lett ; 20(11): 3384-6, 2010 Jun 01.
Article in En | MEDLINE | ID: mdl-20430618
ABSTRACT
The design and synthesis of a novel series of non-steroidal progesterone receptor antagonists is described. Ligand-lipophilicity efficiency (LLE) was used in the selection of a prototype agent for in vivo pharmacology studies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progesterone / Pyrazoles Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2010 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progesterone / Pyrazoles Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2010 Type: Article Affiliation country: United kingdom